Litigation for RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)

✉ Email this page to a colleague

Subscribe to access the full database, or Sign Up
Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
10,272,083	Acerta Pharma B.V. v. Cipla Limited	⤷ Sign Up	2022-02-02		35:271 Patent Infringement	District Court, D. Delaware	None	⤷ Sign Up
10,272,083	⤷ Sign Up	⤷ Sign Up	2022-02-01		35:271 Patent Infringement	District Court, D. Delaware	None	⤷ Sign Up
10,272,083	Acerta Pharma B.V. v. Cipla Limited	⤷ Sign Up	2022-02-03		35:271 Patent Infringement	District Court, D. Delaware	Defendant	⤷ Sign Up
10,272,083	⤷ Sign Up	⤷ Sign Up	2022-02-03		35:271 Patent Infringement	District Court, D. Delaware	None	⤷ Sign Up
10,272,083	Acerta Pharma B.V. v. Sandoz Inc.	⤷ Sign Up	2022-02-03		35:271 Patent Infringement	District Court, D. Delaware	None	⤷ Sign Up
>Patent	>Case Name	>Docket	>Date Filed	>Date Terminated	>Cause	>Court	>Jury Demand	>Link To Docket

Subscribe to access the full database, or Sign Up
Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
10,016,440		⤷ Sign Up	2016-01-19			201	⤷ Sign Up			⤷ Sign Up
10,272,083	Sandoz Inc.	⤷ Sign Up	2023-02-03	02-03-2023		Inter partes review	⤷ Sign Up	08-07-2023		⤷ Sign Up
7,682,612	Celltrion Inc.	⤷ Sign Up	2017-03-31	03-31-2017	WHITE et al	Inter partes review	⤷ Sign Up	10-23-2017		⤷ Sign Up
7,682,612	Celltrion Inc.	⤷ Sign Up	2017-03-31	03-31-2017	GRILLO-LOPEZ WHITE et al	Inter partes review	⤷ Sign Up	10-12-2017		⤷ Sign Up
7,682,612	Pfizer, Inc.	⤷ Sign Up	2017-10-06	11-06-2017	WHITE et al	Inter partes review	⤷ Sign Up	04-30-2018		⤷ Sign Up
>Patent	>Petitioner	>Status	>Filing Date	>Accorded Filing Date	>Patent Owner	>Trial Type	>Trial Number	>Decision Date	>Inventor	>Document Download